Trial conductors
Appears in 1 story
Reported phase 2 results in Nature Metabolism, October 2026
Eight of 17 patients whose fatty liver disease had progressed to scarring saw their fibrosis improve after three 3-week cycles of two drugs. One of 14 on placebo did. The randomized, placebo-controlled result, published in Nature Metabolism, is the first controlled evidence that clearing senescent cells can reverse liver fibrosis in people.
Updated 2 hours ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
